Triggerable Liposome Anesthesia for On-Demand Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pain management options for postoperative or chronic pain require repeated administration of systemic analgesic medications, leading to potential complications and limitations in adjusting the timing, intensity, and duration of anesthetic effect.
Innovation Solution
Development of compositions and methods for repeatable and adjustable on-demand anesthesia using liposome, particle, or microbubble formulations containing site 1 sodium channel blockers and alpha-2-adrenergic agonists, triggered by external stimuli such as near-infrared irradiation, ultrasound, or magnetic fields.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If sustained drug release systems are used to provide prolonged local anesthesia, then the duration of action is improved, but the system loses the ability to adjust timing and intensity of anesthetic effect
Solution Approach 1:
The patent transforms a static sustained-release system into a dynamic on-demand release system by incorporating triggerable elements that respond to external stimuli (light, ultrasound, magnetic fields). This allows the system to switch between different states (storage, release, pause) providing both prolonged duration and adjustable timing/intensity of anesthetic effect.
Solution Approach 2:
The patent introduces triggerable elements (photosensitive compounds, ultrasound-sensitive compounds, magnetically responsive particles) as intermediaries between the external environment and the drug release process. These intermediaries transduce external stimuli into controlled drug release events, enabling on-demand activation while maintaining prolonged duration capability.
2Reliability
If high concentrations of anesthetics are used to overcome perineurial barrier permeability, then the effectiveness of nerve blockade is improved, but the toxicity increases
Solution Approach 1:
The patent uses permeation-enhancing compounds and triggerable elements as intermediaries to facilitate drug delivery through the perineurial barrier. These intermediaries enable effective delivery of lower concentrations of anesthetic by improving permeability through mechanisms such as transient barrier disruption or enhanced transcellular transport, thereby reducing toxicity while maintaining effectiveness.
Solution Approach 2:
The patent employs compounds that can transiently alter the physical or chemical parameters of the perineurial barrier (such as increasing permeability through pH changes, membrane fluidity modification, or transient disruption). This allows effective delivery of anesthetics at lower, less toxic concentrations by temporarily changing barrier properties to facilitate drug passage.
3Reliability
If repeated administration of systemic analgesic medications is used to manage pain, then the pain relief effectiveness is improved, but the risk of complications and clouding of sensorium increases
Solution Approach 1:
The patent extracts the anesthetic from systemic circulation and delivers it directly to the target nerve via localized injection with triggerable release. This eliminates the need for repeated systemic administration, providing effective pain relief while avoiding the complications and sensorium clouding associated with systemic opioids and analgesics.
Solution Approach 2:
The patent creates a self-contained localized delivery system where the triggerable elements respond to external stimuli to release anesthetic directly at the nerve site. This self-service mechanism provides sustained pain relief without requiring repeated external interventions or systemic medication administration, thereby avoiding associated complications.
4Productivity
If permeation enhancers are used to increase perineurial barrier permeability, then the drug delivery efficiency is improved, but the risk of myotoxicity increases
Solution Approach 1:
The patent uses compounds that transiently and reversibly alter perineurial barrier parameters (such as pH, membrane fluidity, or junctional tightness) to enhance permeability. These parameter changes are controlled in time and space, providing sufficient drug delivery efficiency while minimizing exposure time and concentration that could cause myotoxicity.
Solution Approach 2:
The patent employs periodic or pulsed activation of permeation enhancement through triggerable elements. The permeation-enhancing effect is activated only when needed (upon external stimulus) and deactivated afterward, providing efficient drug delivery windows while minimizing continuous exposure that could lead to myotoxicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Achieves repeated, high-permeation analgesia over extended periods with minimal toxicity and improved efficiency, allowing for prolonged nerve blockade duration and adjustable drug release in response to changing needs.
Implementation Method 1
The liposomes can be triggered to release their content in a repeated and adjustable on-demand fashion by application of appropriate external stimuli, such as near-infrared irradiation
Implementation Method 2
exemplary sonosensitive triggerable elements include protoporphyrin IX
Implementation Method 3
exemplary magnetically-responsive triggerable elements include iron oxide nanoparticles
Data Source
Figure 1~4B
Figure 5~6B
Figure 7A~7C
AI summary
Compositions and methods for administration of local anesthetics that are delivered by a single injection and enable repeated on-demand or high influx analgesia over extended periods have been developed. Pharmaceutical compositions including an effective amount of one or more sodium channel blockers including site 1 sodium channel blockers, optionally one or more alpha-2-adrenergic agonists, which are optionally encapsulated in liposomes, particles or microbubbles, and one or more triggerable elements are provided. The triggerable elements allow delivery of the encapsulated anesthetic drugs when an appropriate triggering stimuli are applied. Exemplary triggering agents or stimuli include near-infrared irradiation, UV- and visible light, ultrasound and magnetic field. In one embodiment, ultrasound is used to trigger a burst of microbubbles to enhance penetration of local anesthetic.